Concentrated Australian Share Fund
Fund overview
The Investors Mutual Concentrated Australian Share Fund provides exposure to an actively managed, concentrated portfolio of quality shares listed on the ASX. The Fund will aim to provide attractive investment opportunities for investors seeking medium to long term capital growth with income. The Fund applies IML’s conservative value based investment philosophy with a long term focus and aims to deliver consistent returns to clients.
Videos
Investors Mutual Concentrated Australian Share Fund
Hugh Giddy provides an introduction to the Investors Mutual Concentrated Australian Share Fund, the companies it invests in, the outcomes of the fund & how it differs from a stereotypical concentrated fund.
Fund Facts
-
Portfolio Managers:
Hugh Giddy
-
Benchmark:
S&P/ASX 300 Accumulation Index
-
Inception:
1 Sept 2010
-
ARSN:
145 759 879
-
APIR:
IML0010AU
-
Distribution Frequency:
Generally semi-annually
-
Performance fee:
10.25% (10% inclusive of the net effect of GST) of investment returns made in excess of 2% above the Benchmark.
-
Management fee:
0.993% p.a. of the net assets of the fund (includes GST)
Investment Objective
The Fund aims to provide a rate of return (after fees and expenses and before taxes) which exceeds the return of the S&P/ASX 300 Accumulation Index on a rolling five year basis.
Investment Strategy
The Fund will invest in a concentrated portfolio of quality ASX listed Australian and New Zealand shares, where these shares are identified by our investment team as being undervalued.
Net Performance
Unit Prices
Distribution Information
Period Ending |
Distribution |
December 2021 |
2.0 cpu |
June 2021 |
1.5 cpu |
December 2020 |
1.0 cpu |
June 2020 |
2.4 cpu |
December 2019 |
2.25 cpu |
June 2019 |
3.8 cpu |
December 2018 |
2.25 cpu |
June 2018 |
2.9 cpu |
December 2017 |
2.0 cpu |
June 2017 |
2.7 cpu |
December 2016 |
1.5 cpu |
June 2016 |
2.4 cpu |
December 2015 |
1.5 cpu |
June 2015 |
2.2 cpu |
December 2014 |
2.5 cpu |
June 2014 |
12.0 cpu |
Past performance is not indicative of future performance as a result past distributions are not indicative of future distributions.For more information please refer to our Distributions page
Ratings and Awards
Researcher |
Rating |
Morningstar |
Gold |
Lonsec |
Contact IML for the most recent rating |
Zenith |
Recommended |
For the most recent research house ratings report please contact your state manager.
© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘class service’ have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information at //www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser.
The Zenith Investment Partners (“Zenith”) Australian Financial Services License No. 226872 rating (assigned 24 June 21) referred to in this document is limited to “General Advice” (as defined by the Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Zenith usually charges the product issuer, fund manager or a related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessment’s and at http://www.zenithpartners.com.au/RegulatoryGuidelines